We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
RAC Retreats from Regulatory Role.
- Authors
Walton, Susan
- Abstract
The article discusses certain issues related to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee (RAC). As biotechnology is shifting from small-scale to industrial use, the RAC finds itself confronted with issues, namely equipment evaluation and worker safety, that do not fall under its purview. It has been stated by NIH officials that the RAC is not a regulatory one, yet it is serving that function for industrial use, wrote member Richard Goldstein of the RAC with Sheldon Krimsky of Tufts University in a statement issued to members of the RAC at a meeting held from June 5-6, 1980. Meanwhile, the RAC has approved research proposal by Ronald W. Davis of Stanford University that will be the first to allow the release of recombinant products into the environment.
- Subjects
UNITED States; NATIONAL Institutes of Health (U.S.). Recombinant DNA Advisory Committee; BIOTECHNOLOGY; INDUSTRIAL safety; TRADE regulation; GOLDSTEIN, Richard; KRIMSKY, Sheldon; DAVIS, Ronald W.; RECOMBINANT DNA
- Publication
BioScience, 1980, Vol 30, Issue 7, p448
- ISSN
0006-3568
- Publication type
Article
- DOI
10.2307/1307944